Status: Not Enrolling
ClinicalTrials.gov Identifier: NCT02462889
Pro-Con: A Prospective, Single-blind, Randomized Study to Evaluate Intravitreal Aflibercept Injection (IAI) versus Sham as PROphylaxis against CONversion to Neovascular Age-related Macular Degeneration (AMD) in High-Risk Eyes
Condition: AMD
Study Type: Interventional
Duration: 24 months
Eligibility:
For additional information, please click here
Back to Clinical Research